收藏切换
Exploration of Protective Mechanism of Jiawei Zexie Decoction(加味泽泻汤)on Vascular Endothelium in High-Fat Diet-Fed Rats Based on PI3K/AKT/NF-κB Pathway
收藏切换
Yuwei HE1, Di LIU1, Shujun GUAN1, Ming GONG2, Wenlong WU1, Ting LI1, Yan ZHANG3, Xin ZHAO2
Chinese Archives of Traditional Chinese Medicine | 2026, 44(3) : 120 - 128
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2026, 44(3): 120-128
• Target on National Project •
Exploration of Protective Mechanism of Jiawei Zexie Decoction(加味泽泻汤)on Vascular Endothelium in High-Fat Diet-Fed Rats Based on PI3K/AKT/NF-κB Pathway
Full
Yuwei HE1, Di LIU1, Shujun GUAN1, Ming GONG2, Wenlong WU1, Ting LI1, Yan ZHANG3, Xin ZHAO2
Affiliations
  • 1.Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning, China
  • 2.The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, Liaoning, China
  • 3.Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang 110032, Liaoning, China
Published: 2026-03-10 doi: 10.13193/j.issn.1673-7717.2026.03.023
Outline
收藏切换
Objective

To explore the protective effect and underlying mechanisms of Jiawei Zexie Decoction(加味泽泻汤, JWZXD)on endothelial injury in hyperlipidemia through the phosphatidylinositol-3-kinase/protein kinase B/nuclear factor-κB(PI3K/AKT/NF-κB)pathway.

Methods

Thirty 4-week-old male SD rats were randomly divided into a normal group(n = 6)and a modeling group(n = 24). The modeling group was fed a high-fat diet for 20 weeks to establish a hyperlipidemia model. The 24 successfully modeled rats were then randomly divided into four groups:the model group, the JWZXD standard dose group, the JWZXD high-dose group, and the atorvastatin calcium group. After 4 weeks of drug intervention, the body weight, four blood lipid parameters[total cholesterol(TC), triglyceride(TG), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein cholesterol(LDL-C)]and endothelial function-related indicators[endothelin-1(ET-1), nitric oxide(NO)]were detected, and the aortic tissue was stained with hematoxylin and eosin(HE)to evaluate the therapeutic effect of JWZXD on endothelial injury in hyperlipidemia. Subsequently, the network pharmacology analysis was conducted to further explore the pharmacological mechanisms at play. The active components and targets of JWZXD were predicted using the TCMSP, Swiss Target Prediction, HERB, ETCM and BATMAN databases. The targets related to hyperlipidemia and endothelial dysfunction were retrieved from the GeneCards, OMIM, DisGeNET and TTD databases. Venn diagrams, protein-protein interaction(PPI)networks and enrichment analysis were employed to identify mechanism pathways. Real-time fluorescent quantitative PCR(RT-qPCR)was used to detect the mRNA expressions of PI3K, AKT1, NF-κB, IL-6 and TNF in each group and Western blot analysis was conducted to measure the expression levels of endothelial injury pathway-related proteins p-PI3K, PI3K, p-AKT, AKT and NF-κB.

Results

Compared with the normal group, the model group showed increased levels of TC, TG, LDL-C and ET-1(P < 0.01), and decreased levels of HDL-C and NO(P < 0.05, P < 0.01). Network pharmacology analysis identified 29 active ingredients in JWZXD, including 24-acetyl alismol A, kaempferol, alismol A, alismol B, alismol C and atractylenolide I. After PPI network and topological analysis, 62 core targets such as IL-6, AKT1, TNF, IL-1B and STAT3 were identified. Enrichment analysis using the DAVID platform mainly identified 156 signaling pathways, including the PI3K-AKT signaling pathway, lipids and atherosclerosis, HIF-1 signaling pathway, TNF signaling pathway and EGFR tyrosine kinase inhibitor resistance. Animal experiment results showed that compared with the model group, JWZXD down-regulated the mRNA expression levels of PI3K, AKT1, NF-κB, IL-6, TNF, etc., and up-regulated the protein expression levels of endothelial p-PI3K, PI3K, p-AKT and AKT(P < 0.05, P < 0.01)while down-regulated the protein expression of NF-κB(P < 0.05, P < 0.01).

Conclusion

JWZXD has a good effect on lowering blood lipids, inhibiting the expression of inflammatory factors and protecting vascular endothelial function. Its mechanism may be achieved through the activation of the PI3K/AKT/NF-κB signaling pathway.

Jiawei Zexie Decoction(加味泽泻汤)  /  hyperlipidemia  /  endothelial dysfunction  /  network pharmacology  /  PI3K/AKT/NFκB pathway
赫雨薇, 刘迪, 官蜀钧, 宫铭, 吴文龙, 李婷, 张艳, 赵昕. 基于PI3K/AKT/NF-κB通路探究加味泽泻汤对高脂饲喂大鼠血管内皮保护作用机制. 中华中医药学刊, 2026 , 44 (3) : 120 -128 . DOI: 10.13193/j.issn.1673-7717.2026.03.023
Yuwei HE, Di LIU, Shujun GUAN, Ming GONG, Wenlong WU, Ting LI, Yan ZHANG, Xin ZHAO. Exploration of Protective Mechanism of Jiawei Zexie Decoction(加味泽泻汤)on Vascular Endothelium in High-Fat Diet-Fed Rats Based on PI3K/AKT/NF-κB Pathway[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (3) : 120 -128 . DOI: 10.13193/j.issn.1673-7717.2026.03.023
Year 2026 volume 44 Issue 3
93
17
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2026.03.023
  • Online Date:2026-10-14
  • Published:2026-03-10
Article Data
Affiliations
History
Funding
Affiliations
    1.Liaoning University of Traditional Chinese Medicine, Shenyang 110847, Liaoning, China
    2.The Second Affiliated Hospital of Dalian Medical University, Dalian 116023, Liaoning, China
    3.Affiliated Hospital, Liaoning University of Traditional Chinese Medicine, Shenyang 110032, Liaoning, China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2026.03.023
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT